ENDS Public Health: Difference between revisions

Fixed error in order under Page Editors / Added content
(Fixed error in order under Page Editors / Added content)
Line 5: Line 5:
*'''PAGE EDITORS - Please only add Studies, Surveys, Papers in this format to keep page consistent for all viewers.'''
*'''PAGE EDITORS - Please only add Studies, Surveys, Papers in this format to keep page consistent for all viewers.'''
**Topic
**Topic
**Year (list new to old) Name of Study (In link format to the study)
**Note here if animal study (leave blank if not)
**Note here if animal study (leave blank if not)
**Year (list new to old) Name of Study (In link format to the study)
**Brief Summary
**Brief Summary
**Link to PDF Version
**Link to PDF Version
Line 213: Line 213:
Between 2014 and 2019 in England, at the population level, monthly changes in the prevalence of accurate harm perceptions among current tobacco smokers were strongly associated with changes in e-cigarette use.
Between 2014 and 2019 in England, at the population level, monthly changes in the prevalence of accurate harm perceptions among current tobacco smokers were strongly associated with changes in e-cigarette use.


===2020: NEWS THAT TAKES YOUR BREATH AWAY: RISK PERCEPTIONS DURING AN OUTBREAK OF VAPING-RELATED LUNG INJURIES===
===2020: [https://link.springer.com/article/10.1007/s11166-020-09329-2 NEWS THAT TAKES YOUR BREATH AWAY: RISK PERCEPTIONS DURING AN OUTBREAK OF VAPING-RELATED LUNG INJURIES]===
The  increase  in  e-cigarette  risk  perceptions  might  discourage  adult  smokers  from using e-cigarettes  as  a way  to  quit  smoking,  despite  evidence  from a  clinical trial  that  ecigarettes  are  a more  effective  cessation  method  than  FDA-approved products  such  as  the nicotine  patch.
The  increase  in  e-cigarette  risk  perceptions  might  discourage  adult  smokers  from using e-cigarettes  as  a way  to  quit  smoking,  despite  evidence  from a  clinical trial  that  ecigarettes  are  a more  effective  cessation  method  than  FDA-approved products  such  as  the nicotine  patch.
Our econometric results suggest that the immediate impact of the first information shock was to increase the fraction of respondents who perceived e-cigarettes as more harmful than smoking by about 16 percentage points.  More  targeted advice  about  the  risks  of  THC  e-cigarettes (vs nicotine products)  might have  more  effectively  reduced  the  use  of  those  products,  potentially  preventing  EVALI  cases.
Our econometric results suggest that the immediate impact of the first information shock was to increase the fraction of respondents who perceived e-cigarettes as more harmful than smoking by about 16 percentage points.  More  targeted advice  about  the  risks  of  THC  e-cigarettes (vs nicotine products)  might have  more  effectively  reduced  the  use  of  those  products,  potentially  preventing  EVALI  cases.
*[https://documentcloud.adobe.com/link/review?uri=urn:aaid:scds:US:12fcbbc8-dece-407e-9669-8c22ad2b395e PDF Version]
*Citation: Dave, D., Dench, D., Kenkel, D. et al. News that takes your breath away: risk perceptions during an outbreak of vaping-related lung injuries. J Risk Uncertain 60, 281–307 (2020). doi: 10.1007/s11166-020-09329-2
*Acknowledgement: Dhaval Dave acknowledges support through grant R01DA039968 from the National Institute on Drug Abuse. The authors are grateful to Cornell University and the Health Thought Leadership Network at Bentley University for funding the data collection.




Line 222: Line 225:


==Propylene Glycol==
==Propylene Glycol==
===2009: Propylene glycol in e cigarettes might keep us healthy, says researchers===
“Propylene glycol, the primary ingredient in the electronic cigarette cartridge, may be a powerful deterrent against pneumonia, influenza, and other respiratory diseases when vaporized and inhaled according to a study by Dr. Oswald Hope Robertson. Decades before the e cigarette was invented, a study was conducted by Dr. Robertson of the University of Chicago's Billings Hospital in 1942 on inhalation of vaporized propylene glycol in laboratory mice. A more in-depth article was printed in the 1942 issue of TIME Magazine http://www.time.com/time/magazine/article/0,9171,932876,00.html for November 16th. "Dr. Robertson placed groups of mice in a chamber and sprayed its air first with propylene glycol, then with influenza virus. All the mice lived. Then he sprayed the chamber with virus alone. All the mice died."”
The researchers also found that "the propylene glycol itself was a potent germicide. One part of glycol in 2,000,000 parts of air would--within a few seconds--kill concentrations of air-suspended pneumococci, streptococci and other bacteria numbering millions to the cubic foot."
===1942: THE BACTERICIDAL ACTION OF PROPYLENE GLYCOL VAPOR ON MICROORGANISMS SUSPENDED IN AIR. I===
It has been found that propylene glycol vapor dispersed into the air of an enclosed space produces a marked and rapid bactericidal effect on microorganisms introduced into such an atmosphere in droplet form. Concentrations of 1 gm. of propylene glycol vapor in two to four million cc. of air produced immediate and complete sterilization of air into which pneumococci, streptococci, staphylococci, H. influenzae, and other microorganisms as well as influenza virus had been sprayed….


==Weight==
==Weight==


===2018: Lack of Substantial Post-Cessation Weight Increase in Electronic Cigarettes Users===
“Conclusion: Within the study limitations, EC use may help smokers attenuate cigarette consumption or remain abstinent, as well as reduce their post-cessation weight increase. The potential role of the e-vapour category for harm minimization in relation to tobacco and/or food abuse requires confirmation from larger prospective studies. Moreover, the observed lack of post-cessation weight gain in those who reduced substantially cigarette consumption by switching to ECs (i.e., dual users) is an interesting finding and calls for further research investigating the role of nicotine in weight control. Meanwhile, these preliminary findings should be communicated to smokers and particularly to weight-conscious smokers intending to quit.
By combining substantial reduction of smoking with prevention of post-cessation weight gain, EC-based interventions may promote an overall improvement in quality of life. Considering that the negative effects of weight increase could overshadow the health benefits of smoking abstinence, it is important to stimulate more research in this area.”
===2018: E-cigarettes and Weight Loss—Product Design Innovation Insights From Industry Patents===
E-cigarettes may be presented to cigarette users as a possible solution to support smoking cessation and address the fear of weight gain.
===2017: Could Vaping be a New Weapon in the Battle of the Bulge?===
Obesity is set to overtake tobacco smoking in many countries as the primary cause of several high-cost diseases. Tobacco smoking mitigates weight gain through nicotine’s effect on the brain and metabolism.
There have been some reports among vapers that vaping is helping to mitigate weight gain after stopping smoking and or vaping is helping them to control their weight. There are several potential mechanisms by which vaping, in addition to the direct effects of nicotine, could facilitate weight control, these include taste perception, physical mouthfeel, and sensation and behavioral replacement.